Novartis Ag-adr (NVS) Financial News - U.S. FDA advisory meetings through Sept. 13
Novartis Ag-adr (NVS)
U.S. FDA advisory meetings through Sept. 13
2011-07-21 01:02:06Quote: Bisphosphonates for the treatment and prevention of osteoporosis include: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets by Merck & Co Inc (MRK.N); ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and ACTONEL WITH CALCIUM (Copackaged) (risedronate sodium with calcium carbonate) tablets by Warner Chilcott LLC (WCRX.O); BONIVA (ibandronate sodium) tablets and injection by Roche Therapeutics Inc (ROG.VX); RECLAST (zoledronic acid) injection by Novartis Pharmaceuticals Corp (NOVN.VX); and the generic equivalents for these products, if any. ARTHRITIS ADVISORY COMMITTEE DATE: Sept. 13, time TBD LOCATION: TBD CONTACT: Philip Bautista, 301-796-9001 The committee will discuss the anti-nerve growth factor (Anti-NGF) drug class that is currently under development and the safety issues possibly related to these drugs. The committee will be asked to determine whether reports of joint destruction represent a safety signal related to the Anti-NGF class of drugs, and whether the risk-benefit balance for these drugs favors continued development of the drugs as analgesics.(Reporting by Alina Selyukh and Anna Yukhananov; Editing by Tim Dobbyn)...
Open whole article (external link)
Other Financial and Stock Market News concerning Novartis Ag-adr
Novartis begins shipment of Fluvirin(R) seasonal influenza vaccine to US customers for 2011-2012 influenza season (2011-07-18 05:50:28)